Press Releases

Taconic Biosciences Launches New Immuno-oncology Mouse Model

Taconic Biosciences Launches New Immuno-oncology Mouse Model

Expands and Broadens Taconic Biosciences' Immuno-oncology Portfolio Application Rensselaer, NY — January 31, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its premier immuno-oncology portfolio with the launch of the new B2m-NOG mouse model. Immuno-oncology leverages the body's immune system to fight cancer, increasing the ability to target the disease. Animal models used in this therapeutic development include special mice,...  Read More

Taconic Biosciences Opens New Model Generation Facility

Taconic Biosciences Opens New Model Generation Facility

New State-of-the-Art Laboratories in Leverkusen, Germany Rensselaer, NY — January 13, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, opened a new model generation facility in Leverkusen, Germany. This location houses model generation services, replacing the previous Taconic site in Cologne, Germany. Custom genetically modified animal models are critical to the drug discovery process. Taconic leads the industry in providing model...  Read More

Taconic Biosciences Announces New San Diego Location

Taconic Biosciences Announces New San Diego Location

Local Commercial Animal Model Production and Colony Management Services Available to West Coast Customers Rensselaer, NY — January 2, 2020 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the availability of both commercial animal model production and colony management services through a new location in San Diego. Taconic can now provide critical drug discovery research solutions locally to west coast customers....  Read More

Taconic Biosciences Launches Alzheimer's Disease Mouse Model

Taconic Biosciences Launches Alzheimer's Disease Mouse Model

Proven Model Available Exclusively From Taconic Biosciences Rensselaer, NY — November 4, 2019 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its robust neurodegeneration portfolio with the launch of a new Alzheimer's disease model, the ARTE10 mouse model. Exclusively available from Taconic, the ARTE10 is a transgenic mouse model expressing mutant human APP and PS1 genes. This combination manifests in early...  Read More

Taconic Biosciences Announces New Scientific Advisory Board Member

Taconic Biosciences Announces New Scientific Advisory Board Member

Dr. Frank Sistare Joins Taconic Biosciences' Scientific Advisory Board Rensselaer, NY — October 17, 2019 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the addition of Frank Sistare, PhD to its Scientific Advisory Board (SAB). Dr. Sistare joins existing SAB members Andrew Goodman, PhD, David Hill, PhD, and Robert Rosenthal, PhD. The SAB will continue to collaborate with Taconic's management in...  Read More

Taconic Biosciences Participates in Second Rodent Research Reference Mission to the International Space Station

Taconic Biosciences Participates in Second Rodent Research Reference Mission to the International Space Station

Resulting Studies Will Provide Critical Reference Data to Drive Advancements in Human Health Rensselaer, NY — September 3, 2019 - Taconic Biosciences, a global leader in providing genetically engineered animal model solutions, announces its participation in the second Rodent Research Reference (RRR) mission to the International Space Station. Taconic has a history with NASA dating back to 1985. While previous NASA programs were collaborations with academic and/or...  Read More

Taconic Biosciences Releases First Off-the-Shelf NASH Animal Model

Taconic Biosciences Releases First Off-the-Shelf NASH Animal Model

New Model Saves Researchers Time as They Study the Devastating Disease Rensselaer, NY — July 29, 2019 - Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the launch of the first commercially available diet-induced NASH (nonalcoholic steatohepatitis) rodent model. NASH is a dangerous subtype of nonalcoholic fatty liver disease (NAFLD) and has recently garnered increased attention in the biomedical community due to...  Read More

Taconic Biosciences is First and Only Animal Vendor to Announce All Commercial Mouse Colonies Free of New Pathogen

Taconic Biosciences is First and Only Animal Vendor to Announce All Commercial Mouse Colonies Free of New Pathogen

Rensselaer, NY — June 3, 2019 - Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces that all commercial mouse colonies and contract mouse breeding barriers are free of a newly discovered pathogen. Taconic is the first and only commercial animal vendor to exclude mouse kidney parvovirus from its animals at all health standards. In an October 2018 Cell paper, an Australian and...  Read More

Taconic Biosciences Launches TruBIOME® to Create Animal Models with Custom Microbiome Profiles

Taconic Biosciences Launches TruBIOME® to Create Animal Models with Custom Microbiome Profiles

Rensselaer, NY — April 15, 2019 - Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the launch of TruBIOME®, a first of its kind solution enabling the generation and maintenance of mice with custom microbiome profiles. TruBIOME® was developed to meet the research community's need for a microbiome solution that affords increased predictability, reproducibility, and systems biology insight within mouse model use....  Read More

Taconic Biosciences Licenses the Wild Mouse Gut Microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases

Taconic Biosciences Licenses the Wild Mouse Gut Microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases

Rensselaer, NY — April 1, 2019 - Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces it has obtained a license to the Wild Mouse gut microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). Investigators at the NIDDK studied wild mice gut microbiota, finding it differs dramatically from that of...  Read More

Close

Welcome! Tell us a little about yourself